Bavarian Nordic Announces Interim Results for the First Three Months of 2025

About this update from Bavarian Nordic A/s

[{"type":"image","alt":"Bavarian Nordic A/S","displaySize":"","headline":null,"caption":"Bavarian Nordic A/S","className":"","disableSlideshowImg":false,"size":{"original":{"width":224,"height":118,"url":"https://media.zenfs.com/en/globenewswire.com/8b66f55ff95ddf48491741d682cbdfa0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/X7d037B4FI93H1mEWMcPsw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/8b66f55ff95ddf48491741d682cbdfa0","width":224,"height":118}},"lazy":false},{"type":"text","content":"COPENHAGEN, Denmark, May 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first three months of 2025.","length":170,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue for the first three months increased by 62% to DKK 1,347 million, reflecting a strong performance in both Travel Health and Public Preparedness.","length":152,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Travel Health revenue increased by 52% to DKK 680 million compared to the first quarter of 2024, primarily driven by increased demand for rabies and tick-borne encephalitis (TBE) vaccines.","length":188,"tagName":"p"}]},{"val":[{"type":"text","content":"Public Preparedness revenue increased by 83% to DKK 629 million compared to the first quarter of 2024. This exceeded initial expectations due to successful efforts to advance the deliveries of a few, but larger, existing orders into the first quarter.","length":251,"tagName":"p"}]},{"val":[{"type":"text","content":"Other revenue was DKK 37 million.","length":33,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":472,"olType":false}]},{"val":[{"type":"text","content":"The operating profit (EBITDA) was DKK 420 million, corresponding to an EBITDA margin of 31%.","length":92,"tagName":"p"}]},{"val":[{"type":"text","content":"Financial guidance for the full year is maintained at a revenue of DKK 5,700-6,700 million and an EBITDA margin of 26-30%.","length":122,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":838,"olType":false},{"type":"table","headerItems":[],"items":[{"val":[{"style":"width:349.54px;border-bottom:solid black 1pt;text-align:left;vertical-align:middle;vertical-align:top;","val":[{"type":"text","content":"DKK million","length":11,"tagName...

More updates from Bavarian Nordic A/s